Net Profit Margin: -34.06%

Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the net profit margin high or low?

The net profit margin of -34.06% is 84% below its 5-year average of -18.54%, near the high end of its 5-year range (-759.45%–75.70%).

45.96% above its 12-month average of -63.03%.

XLO Net Profit Margin Metrics

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin = Net Income / Revenue

Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Net Profit Margin FAQ

What is the net profit margin for Xilio Therapeutics, Inc. (XLO)?

The net profit margin for XLO stock is -34.06%.

Is Xilio Therapeutics, Inc.'s net profit margin high or low?

The net profit margin of -34.06% is 84% below its 5-year average of -18.54%, near the high end of its 5-year range (-759.45%–75.70%).

What is the TTM average net profit margin for Xilio Therapeutics, Inc. (XLO)?

The TTM average net profit margin for XLO stock is -63.03%.

What is the 3Y average net profit margin for Xilio Therapeutics, Inc. (XLO)?

The 3Y average net profit margin for XLO stock is -210.59%.

What is the 5Y average net profit margin for Xilio Therapeutics, Inc. (XLO)?

The 5Y average net profit margin for XLO stock is -18.54%.

Related Metrics